Erratum: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity (Oncotarget (2014) 5 (1502–1514) DOI: 10.18632/oncotarget.1609)

Adrienne L. Watson, Bryant J. Keller, Kyle A. Williams, Namrata N. Damle, Samuel J. Finnerty, Leah K. Anderson, Andrew D. Greeley, Vincent W. Keng, Eric P. Rahrmann, Amanda L. Halfond, Natasha M. Powell, Margaret H. Collins, Tilat Rizvi, Christopher L. Moertel, Nancy Ratner, David A. Largaespada

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Erratum: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity (Oncotarget (2014) 5 (1502–1514) DOI: 10.18632/oncotarget.1609)'. Together they form a unique fingerprint.

Medicine & Life Sciences